Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 4

Sponsor Class

OTHER 4NIH 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 4

Conditions

Breast Neoplasms 309Neoplasms 269Prostatic Neoplasms 189Precursor Cell Lymphoblastic Leukemia-Lymphoma 186Lymphoma 184Leukemia, Lymphocytic, Chronic, B-Cell 161Melanoma 158Leukemia 154Lymphoma, Non-Hodgkin 149Leukemia, Myeloid, Acute 149Brain Neoplasms 143Carcinoma, Non-Small-Cell Lung 141Lymphoma, Large B-Cell, Diffuse 128Colonic Neoplasms 128Lymphoma, Follicular 123Burkitt Lymphoma 119Ovarian Neoplasms 117Lung Neoplasms 116Glioblastoma 116Lymphoma, Mantle-Cell 114Unspecified Adult Solid Tumor, Protocol Specific 107Rectal Neoplasms 103Sarcoma 102Multiple Myeloma 102Gliosarcoma 102Hodgkin Disease 97Carcinoma, Renal Cell 97Lymphoma, B-Cell, Marginal Zone 96Astrocytoma 95Carcinoma, Ovarian Epithelial 93

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × NIH × Malaria × Clear all
NCT01196520 2020-05-22

Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)

National Institutes of Health Clinical Center (CC)

Completed
4,893 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Malaria, Epstein-Barr Virus Infections

NCT00341250 2017-07-02

Malaria Vaccine in Children in Mali

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
900 enrolled
Lymphoid

Burkitt Lymphoma, Malaria

NCT00343005 2017-07-02

Experimental Vaccine for Malaria in Adults in Mali

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
54 enrolled
Lymphoid

Burkitt Lymphoma, Malaria, Malaria, Falciparum

NCT00414336 2017-07-02

Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
150 enrolled
Lymphoid

Burkitt Lymphoma, Malaria

Data powered by HemOnc (CC BY 4.0) Colophon âš¡